Cardiopulmonary Phenotypes and Protein Signatures in Children With Down Syndrome

Emily M DeBoer1,2,3, Kristine Wolter-Warmerdam2, Robin R Deterding1,2

  • 1Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO, USA.

Clinical Pediatrics
|June 12, 2023
PubMed

Insights

Pulmonary diagnoses are common in children with Down syndrome (DS), affecting half by age 10. These lung conditions appear to occur independently of heart disease and pulmonary hypertension (PH).

Area of Science:

  • Pediatric pulmonology
  • Genetics
  • Cardiology

Background:

  • Pulmonary disease, lower respiratory tract infections, and pneumonia are leading causes of death in individuals with Down syndrome (DS).
  • The prevalence and independence of pulmonary diagnoses in children with DS, particularly concerning cardiac disease and pulmonary hypertension (PH), remain unclear.

Purpose of the Study:

  • To investigate the frequency of pulmonary diagnoses in children with Down syndrome.
  • To determine if these pulmonary diagnoses occur independently of cardiac disease and pulmonary hypertension (PH).

Main Methods:

  • Examined cardiopulmonary phenotypes in a cohort of 1248 children with DS.
  • Conducted aptamer-based proteomic analysis of blood in a subset of 120 children.

Main Results:

  • By age 10, 50.8% (634/1248) of children with DS had co-occurring pulmonary diagnoses.
  • Proteomic analysis revealed distinct protein pathways between children with pulmonary diagnoses and those with cardiac disease and/or PH.
  • Heparin sulfate-glycosaminoglycan degradation, nicotinate metabolism, and elastic fiber formation pathways were most prominent in children with pulmonary diagnoses.

Conclusions:

  • Pulmonary diagnoses are highly prevalent in children with Down syndrome.
  • Evidence suggests pulmonary diagnoses in this population may arise independently of cardiac disease and PH.
  • Specific protein pathways are associated with pulmonary conditions in children with DS.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
17
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
40.7K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
12
Karyotyping01:17

Karyotyping

Overview
61.9K